RFRoberto Ferraresi

Roberto Ferraresi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roberto Ferraresi has a total of 269 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Digital learning and remote technical support enhancing continuous education in endovascular surgery: Technical aspects and user satisfaction

    by Paolo Spath, Lorenzo Patrone, Andreia Pinelo, Theodosios Bisdas, Roberto Ferraresi, Michael Lichtenberg, Marco Manzi, Giovanni Pratesi, Gioele Simonte, Mauro Gargiulo

  • Open Access

    Quantification of hemodynamic changes and wound healing following transcatheter arterialization of the deep veins in no-option chronic limb-threatening ischemia

    by Peter A. Schneider, Anahita Dua, Richard J. Powell, Daniel G. Clair, Steven A. Abramowitz, Michael C. Siah, Mehdi H. Shishehbor, Roberto Ferraresi


  • Open Access

    A Hemodynamic Scoring System for Optimizing Transcatheter Arterialization of the Deep Veins in No-Option Patients With Chronic Limb-Threatening Ischemia

    by Michael C. Siah, Syed Muhammad Mashhood Ali Bokhari, Anahita Dua, Rick J. Powell, Steven Kum, Steven D. Abramowitz, Michiel Schreve, Daniel van Den Heuvel, Dan G. Clair, Mehdi Shishehbor, et al.

  • Open Access

    Toe pressure measurement in the context of digital artery calcification

    by Rutger H.A. Welling, Daniel A.F. van Den Heuvel, Andrej Schmidt, Roberto Ferraresi, Gert J. de Borst, Olaf J. Bakker

  • Open Access

    Medial artery calcification (MAC) in transcatheter arterialization of deep veins (TADV)

    by Mounika Naidu Boya, Michael Siah, Sara Rose-Sauld, Adriana Rodriguez Alvarez, Isabella Cieri, Shiv Patel, Roberto Ferraresi, Anahita Dua

  • Patterns of Angiographic Remodeling Following Foot Vein Arterialization

    by Roberto Ferraresi, Alessandro Ucci, Michael C. Siah, Daniel A. van Den Heuvel, Fabrizio Losurdo, Steven Kum

    Objective: Foot vein arterialization (FVA) in no-option patients with chronic limb-threatening ischemia (CLTI) provides promising rates of limb salvage and wound healing; however, the precise mechanisms underlying tissue perfusion after FVA are not fully understood. In most cases, FVA creates an arterialized circuit confined inside the foot vein fortress (FVF) upon initial completion. Over the following weeks to months, FVA facilitates a process of vascular remodeling leading to tissue perfusion. The primary objective of this study is to describe a novel classification system of the angiographic patterns of vascular remodeling observed in FVA and to hypothesize their pathophysiology and implications for limb salvage. Methods: This is a retrospective observational case series. We included no-option CLTI patients who underwent clinically-successful FVA (defined as achieving limb salvage with complete wound healing) and clinically-driven angiographic studies during follow-up. We identified 6 types of vascular remodeling: type 0, the arterialized circuit is confined inside the FVF; type 1, expansion of the arterialized circuit into venous systems outside the FVF; type 2, wound-related vascular remodeling leading to wound blush (WB); type 3, venous-arterial fistulas recruiting hibernated arterial segments; type 4, self-pruning of venous outflow; and type 5, promotion of collateral vessel growth with reconstitution of a new calf/foot distribution system. Results: Nineteen patients (12 with hybrid, and 7 with totally percutaneous FVA) were evaluated. The acute result of FVA showed a type 0 pattern in 13 patients (68.4%) and type 1 pattern in 6 (31.6%). During follow-up, patients required 43 new clinically-driven angiographic studies (mean 2.3/patient). The average time between initial FVA and subsequent angiographic studies was 164 ± 325.2 days (2-1895). In the 43 follow-up angiograms, the following pattern distribution was observed: type 0 pattern in 5 (11.6%), type 1 in 29 (67.4%), type 2 in 18 (41.9%), type 3 in 10 (23.3%), type 4 in 4 (9.3%), and type 5 in 7 (16.3%). Conclusion: Vascular remodeling after FVA is a complex process involving multiple pathophysiological mechanisms, resulting in various angiographic patterns. Recognizing these patterns may aid clinicians in developing targeted treatments to enhance FVA efficacy and improve clinical outcomes. Clinical Impact: This study introduces the first classification of angiographic patterns of vascular remodeling following foot vein arterialization (FVA), addressing the significant unpredictability of clinical outcomes despite high technical success in no-option CLTI patients. The primary clinical impact is providing a standardized framework to monitor and interpret the complex FVA maturation process. By recognizing the temporal evolution of these distinct patterns, clinicians can identify patients with suboptimal remodeling. This allows for targeted secondary interventions to guide vascular pathways, enhance tissue perfusion, and ultimately improve rates of wound healing and limb salvage, laying the groundwork for optimizing this limb-saving therapy.

  • The “Woundosome” Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia

    by Lorenzo Patrone, Edoardo Pasqui, Michael S. Conte, Alik Farber, Roberto Ferraresi, Matthew Menard, Joseph L. Mills, John Rundback, Peter Schneider, August Ysa, et al.


  • Endovascular and Surgical Venous Arterialization for No-Option Patients With Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis

    by Alessandro Ucci, Paolo Perini, Antonio Freyrie, Michiel A. Schreve, Çağdaş Ünlü, Eline Huizing, Daniel A. van Den Heuvel, Steven Kum, Mehdi H. Shishehbor, Roberto Ferraresi

    Background: Chronic limb-threatening ischemia (CLTI) is known for its high rates of major amputation and mortality. Conventional revascularization techniques often fail in CLTI patients due to the heavily diseased arteries. Foot vein arterialization (FVA) has been proposed as an alternative technique to provide arterial blood to the foot by using the disease-free venous bed. Objectives: This systematic review and meta-analysis aimed to determine outcomes of surgical FVA (sFVA) and percutaneous FVA (pFVA) at 6 and 12 months post-procedure. Data sources: PubMed, Scopus, Web of Science, and the Cochrane Library databases were searched to identify papers reporting clinical outcomes of sFVA and pFVA published between January 1966 and March 2023. Methods: Databases were searched for eligible studies. A meta-analysis was performed to evaluate the limb salvage rate, overall survival rate, and wound healing rate at 6 and 12 months. Results: A total of 27 studies were included, with 753 patients and 793 limbs. Of the included studies, 16 analyzed the sFVA technique and 11 the pFVA technique. Of the included patients, 86.3% were Rutherford 5/6 in the sFVA group versus 98.4% in the pFVA group. The pooled limb salvage rate at 6 and 12 months was 78.1% and 74.1% in the sFVA group and 81.7% and 78.6% in the pFVA group, respectively. Wound healing rates were not reported in the sFVA group. In the pFVA group, the pooled wound healing rates were 48.1% and 64.5% at 6 and 12 months, respectively. Conclusion: This study showed promising results after FVA among a large population of CLTI patients. In high-risk patients, pFVA is a feasible option with favorable limb salvage and wound healing rates.


  • The Elephant in the Room

    by Alberto Piaggesi, Roberto Ferraresi, Mauro Gargiulo

    Despite its increasing prevalence, severity, and mortality, Diabetic foot syndrome (DFS) still remains an unaddressed critical issue. The management of DFS is adequately performed only in few centers, and clinical outcomes vary, depending on the possibility of patients to access optimal standards of care. To focus on the critical aspects of the management of DFS in Italy with the purpose of suggesting arguments that might have a more general audience, to improve the quality of therapy and accessibility to optimal care, we have written this article.


  • Open Access

    Percutaneous Transluminal Angioplasty for Below-the-Elbow Critical Hand Ischemia: A Systematic Review

    by Ghassan Awad El-Karim, Sean A. Kennedy, Roberto Ferraresi, Jamil A.K. Addas, George D. Oreopoulos, Arash Jaberi, Kong Teng Tan, Sebastian Mafeld

    Purpose: To perform a systematic review assessing the safety and efficacy of percutaneous transluminal angioplasty (PTA) for treatment of critical hand ischemia (CHI) due to below-the-elbow (BTE) obstructive arterial disease. Materials and Methods: MEDLINE and EMBASE systematic searches were performed from inception to December 2020 to identify studies assessing PTA for management of BTE obstructive arterial disease. Three independent reviewers performed abstract selection, data extraction, and quality assessment. The Newcastle-Ottawa Scale was used to assess individual study bias for non-randomized controlled trials. Results: Eight studies comprising 176 patients with obstructive BTE vessel disease were included. All studies had a score >5 on the Newcastle-Ottawa Scale, indicative of high quality. All studies used low-profile balloons (1.5–4 mm) for PTA of stenotic lesions or chronic total occlusions (CTOs). The weighted average technical success and clinical success rates were 89.3% (range = 82%–100%) and 69.9% (range = 19%–100%), respectively, at a mean follow-up of 29.7 ± 17.1 months. The short-term (<30 days) complication rate was low at 4.7% and most commonly included access site hematomas, pseudoaneurysms, and radial artery perforation or re-thrombosis. Nearly 20% of patients required an amputation, and most (96%) were minor (either distal phalanges or digits). Only 2 patients required above-wrist amputations. The primary and secondary patency rate at 5 years were 38% and 54%, respectively. The cumulative 5-year mortality rate was 33.1%. Conclusions: PTA for CHI due to BTE obstructive arterial disease is feasible with a high technical success rate and a low short-term complication rate. Additional long-term comparative studies are required to unequivocally establish the clinical benefit of endovascular treatment compared with conservative management or surgical bypass.